Back to People

Raj Basak, Ph.D.

Associate

About

Raj Basak is an Associate with F-Prime Capital and works across the healthcare sub-sectors including therapeutics, medical technology, and healthcare IT & services. Prior to joining F-Prime, Raj was a member of the Healthcare Investment Banking team at Goldman Sachs in New York where he worked on over $15 billion in announced financing and M&A transactions across biopharma.

Raj received his Ph.D. in Molecular Biophysics & Biochemistry from Yale University and a B.S. in Physics with Research Honors from The Macaulay Honors College at The City College of New York, where he was awarded the Ward medal. Raj’s doctoral research focused on studying the biophysical mechanisms underlying nociception in sensory neurons.

  • Amber Therapeutics is developing Amber-UI, a breakthrough adaptive neuromodulation therapy to treat women suffering with mixed urinary incontinence with the hope of transforming the clinical outcome and quality of life of a large untreated population. Amber-UI runs on the Company’s fully implantable Picostim system that targets the pudendal nerve to both stimulate and sense physiological responses. The therapy is configurable to the individual’s need and can respond dynamically to different events, adapting as needed between modes of operation. Amber’s technology platform is highly versatile and can be used to explore other novel therapy applications in both the pelvis and the broader nervous system, demonstrated by the work being carried out by the Company’s academic partnerships. Learn more at www.amber-tx.com.